These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39298677)
1. Synthesis and Evaluation of Li Z; Jiang Y; Ruan Q; Yin G; Han P; Duan X; Zhang J Mol Pharm; 2024 Oct; 21(10):5305-5314. PubMed ID: 39298677 [TBL] [Abstract][Full Text] [Related]
2. Preparation and Biological Evaluation of [ Xiao D; Duan X; Gan Q; Zhang X; Zhang J Molecules; 2020 Nov; 25(23):. PubMed ID: 33256058 [TBL] [Abstract][Full Text] [Related]
3. Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer. Shimizu Y; Ando M; Watanabe H; Ono M Ann Nucl Med; 2024 Oct; 38(10):847-851. PubMed ID: 38976087 [TBL] [Abstract][Full Text] [Related]
7. Radiation Dosimetry of Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398 [No Abstract] [Full Text] [Related]
8. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA). Ray Banerjee S; Pullambhatla M; Foss CA; Falk A; Byun Y; Nimmagadda S; Mease RC; Pomper MG J Med Chem; 2013 Aug; 56(15):6108-21. PubMed ID: 23799782 [TBL] [Abstract][Full Text] [Related]
9. Clinical translation of a PSMA inhibitor for Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503 [TBL] [Abstract][Full Text] [Related]
10. Development of (99m)Tc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging. Kimura H; Sampei S; Matsuoka D; Harada N; Watanabe H; Arimitsu K; Ono M; Saji H Bioorg Med Chem; 2016 May; 24(10):2251-6. PubMed ID: 27073053 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a New Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of Lu K; Zhang C; Zhang Z; Kuo HT; Colpo N; Bénard F; Lin KS Molecules; 2023 Jun; 28(13):. PubMed ID: 37446782 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024 [TBL] [Abstract][Full Text] [Related]
14. Rational Design and Comparison of Novel Meng L; Fang J; Zhang J; Li H; Xia D; Zhuang R; Chen H; Huang J; Li Y; Zhang X; Guo Z J Med Chem; 2024 May; 67(10):8460-8472. PubMed ID: 38717104 [TBL] [Abstract][Full Text] [Related]
16. Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction. Hensbergen AW; Buckle T; van Willigen DM; Schottelius M; Welling MM; van der Wijk FA; Maurer T; van der Poel HG; van der Pluijm G; van Weerden WM; Wester HJ; van Leeuwen FWB J Nucl Med; 2020 Feb; 61(2):234-241. PubMed ID: 31481575 [TBL] [Abstract][Full Text] [Related]